Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice?

Author(s)
Howes, LG
Griffith University Author(s)
Year published
2007
Metadata
Show full item record
Journal Title
Therapeutics and Clinical Risk Management
Volume
3
Issue
5
Subject
Public Health and Health Services
Publication URI
Collection